RadNet Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 46 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 92.38.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of RadNet Inc is 4.97, ranking 72 out of 75 in the Healthcare Providers & Services industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 547.71M, representing a year-over-year increase of 14.80%, while its net profit experienced a year-over-year increase of 111.17%.
Key Metrics
The current valuation score of RadNet Inc is 7.45, ranking 29 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is -226.35, which is -940.50% below the recent high of 1902.46 and -476.21% above the recent low of -1304.24.
The current earnings forecast score of RadNet Inc is 8.75, ranking 3 out of 75 in the Healthcare Providers & Services industry. The average price target is 91.00, with a high of 98.00 and a low of 86.00.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of RadNet Inc is 6.69, ranking 37 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 69.12 and the support level at 49.53, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of RadNet Inc is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 96.38%, representing a quarter-over-quarter increase of 0.02%. The largest institutional shareholder is The Vanguard, holding a total of 7.45M shares, representing 9.60% of shares outstanding, with 1.18% decrease in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. No risk assessment score is currently available for RadNet Inc. The Healthcare Providers & Services industry's average is 5.72. The company's beta value is 1.51. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.
